View of In vivo MTD study of new potential inhibitors of Proprotein Convertase Subtilisin/Kexin 9 (PCSK9) | European Atherosclerosis Journal

← In vivo MTD study of new potential inhibitors of Proprotein Convertase Subtilisin/Kexin 9 (PCSK9)